J. McCutchan

发表

Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group.

T. Jernigan, I. Grant, J. Stout, 1998, Archives of neurology.

Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss.

C. Fennema-Notestine, T. Jernigan, E. Masliah, 2004, Archives of neurology.

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group.

L. Thal, I. Grant, R. Heaton, 1997, Archives of neurology.

Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders

E. Masliah, I. Grant, R. Heaton, 1997, Annals of neurology.

Cortical Synaptic Density is Reduced in Mild to Moderate Human Immunodeficiency Virus Neurocognitive Disorder

E. Masliah, I. Grant, R. Heaton, 1999, Brain pathology.

The impact of HIV-associated neuropsychological impairment on everyday functioning

Carla J. Reicks, Robert K Heaton, I. Grant, 2004, Journal of the International Neuropsychological Society.

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Terry L. Jernigan, Anthony Gamst, David M. Simpson, 2010, Journal of NeuroVirology.

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

F. Vaida, R. Heaton, R. Ellis, 2009, Neurology.

Effects of comorbidity burden and age on brain integrity in HIV

C. Fennema-Notestine, I. Grant, R. Heaton, 2019, AIDS.

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities

C. Fennema-Notestine, I. Grant, R. Heaton, 2019, Journal of the International Neuropsychological Society.

National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study.

S. Asch, J. McCutchan, A. Gifford, 2000, Medical care.

Incidence of and Risk Factors for Clinically Significant Methicillin-Resistant Staphylococcus aureus Infection in a Cohort of HIV-Infected Adults

J. McCutchan, L. Miller, F. Torriani, 2005, Journal of acquired immune deficiency syndromes.

Low atazanavir concentrations in cerebrospinal fluid

I. Grant, D. Clifford, R. Ellis, 2009, AIDS.

Neurologic complications of HIV disease and their treatment.

B. Ances, R. Ellis, J. McCutchan, 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

I. Grant, D. Clifford, R. Ellis, 2012, AIDS.

Symptom-based framework for assessing quality of HIV care.

S. Asch, J. McCutchan, A. Gifford, 2004, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Genetic Variation in Iron Metabolism Is Associated with Neuropathic Pain and Pain Severity in HIV-Infected Patients on Antiretroviral Therapy

Zhongming Zhao, P. Jia, I. Grant, 2014, PloS one.

COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk for Neurocognitive Impairment in Men Living with HIV.

I. Grant, R. Heaton, R. Ellis, 2019, Journal of acquired immune deficiency syndromes.

Is gender dysphoria dysphoric? Elevated depression and anxiety in gender dysphoric and nondysphoric homosexual and bisexual men in an HIV sample

I. Grant, J. McCutchan, J. Atkinson, 1995, Archives of sexual behavior.

Low CSF Leptin Levels are Associated with Worse Learning and Memory Performance in HIV-infected Men

I. Grant, R. Ellis, J. McCutchan, 2007, Journal of Neuroimmune Pharmacology.

Sensory testing in human immunodeficiency virus type 1-infected men. HIV Neurobehavioral Research Center Group.

L. Thal, I. Grant, J. McCutchan, 1992, Archives of neurology.

Testicular pathologic changes and the pituitary-testicular axis during human immunodeficiency virus infection.

J. McCutchan, M. Grafe, I. Sinha-Hikim, 1999, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Clinical factors related to brain structure in HIV: the CHARTER study

Terry L. Jernigan, Rebecca J. Theilmann, David M. Simpson, 2011, Journal of NeuroVirology.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals

F. Vaida, C. Fennema-Notestine, I. Grant, 2016, Journal of NeuroVirology.

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease

Michael J. Taylor, C. Fennema-Notestine, I. Grant, 2015, Journal of NeuroVirology.

Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection

Michael J. Taylor, C. Fennema-Notestine, T. Jernigan, 2013, Journal of NeuroVirology.

Asymptomatic Malaria Co-infection of HIV-infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood and Biomarkers of Systemic Inflammation.

J. McCutchan, K. Williams, T. Burdo, 2020, Journal of acquired immune deficiency syndromes.

A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis

Jeannie S. Huang, J. McCutchan, L. Meixner, 2009, AIDS.

Neuropsychological performance of HIV-1 infected men with major depression

I. Grant, R. Heaton, J. McCutchan, 1997, Journal of the International Neuropsychological Society.

Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia.

D. Havlir, J. McCutchan, S. Bozzette, 1994, The Journal of infectious diseases.

Alternative Regimens for the Prophylaxis of Mycobacterium avium Complex in Acquired Immune Deficiency Syndrome (AIDS)

J. McCutchan, J. Currier, 1997 .

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

J. McCutchan, S. Bozzette, L. Young, 1990, Annals of internal medicine.

A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group.

C. Kemper, D. Havlir, J. McCutchan, 1997, The Journal of infectious diseases.

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.

C. Kemper, D. Havlir, J. McCutchan, 1996, The New England journal of medicine.

Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.

C. Kemper, D. Havlir, J. McCutchan, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

Michael J. Taylor, J. Hesselink, I. Grant, 2011, Journal of clinical and experimental neuropsychology.

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.

C. Kemper, J. McCutchan, S. Deresinski, 1992, Annals of internal medicine.

Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease.

D. Richman, J. McCutchan, S. Spector, 1992, The Journal of infectious diseases.

Retinal findings and characteristics in AIDS patients with systemic Mycobacterium avium-intracellulare complex and toxoplasmic encephalitis.

W. Freeman, J. McCutchan, R. García, 1997, Ophthalmic surgery and lasers.

Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial

J. McCutchan, D. Forthal, M. Dubé, 1999, The Lancet.

Azithromycin in the prophylaxis of opportunistic infections in AIDS

J. McCutchan, J. McCutchan, 1996, International journal of STD & AIDS.

Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States.

S. Asch, J. McCutchan, A. Gifford, 2001 .

Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Drug Administration.

H. Handsfield, J. McCutchan, L. Corey, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Associations Among Coping Style, Personality, Unsafe Sexual Behavior, Depression, Conflict over Sexual Orientation, and Gender Nonconformity

T. Patterson, I. Grant, J. McCutchan, 1995 .

Two-year prospective study of major depressive disorder in HIV-infected men.

T. Patterson, J. Hesselink, I. Grant, 2008, Journal of affective disorders.

Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.

R. Haubrich, C. Kemper, J. McCutchan, 2003, The Journal of infectious diseases.

Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans

D. Galasko, I. Grant, R. Heaton, 1998, Neuroscience Letters.

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER

I. Grant, D. Clifford, M. Ritchie, 2012, Journal of NeuroVirology.

Transforming growth factor-beta and suppression of humoral immune responses in HIV infection.

J. McCutchan, M. Zachariah, W. Wachsman, 1991, The Journal of clinical investigation.

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.

D. Richman, J. McCutchan, S. Bozzette, 1991, The New England journal of medicine.

The HNRC 500-Neuropsychology of Hiv infection at different disease stages

Michael J. Taylor, N Butters, I Grant, 1995, Journal of the International Neuropsychological Society.

Neurological Symptoms, Not Signs,Are Common in Early HIV Infection.

L. Thal, I. Grant, R. Heaton, 1996, Journal of neuro-AIDS.

Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study.

D. Richman, I. Grant, J. McCutchan, 1988, Archives of general psychiatry.

The impact of concomitant viral pathogens on the course of Pneumocystis carinii pneumonia.

D. Richman, J. McCutchan, S. Spector, 1991, The Journal of protozoology.

Lopinavir with Ritonavir Reduces the HIV RNA Level in Cerebrospinal Fluid

R. Ellis, J. McCutchan, S. Letendre, 2007 .

Gallbladder and bile duct abnormalities in AIDS: sonographic findings in eight patients.

G. Leopold, G. Casola, J. McCutchan, 1988, AJR. American journal of roentgenology.

Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2021, AIDS and Behavior.

Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages

J. McCutchan, C. Wiley, R. Schrier, 1993, Journal of virology.

Influence of colony type on susceptibility of gonococci to killing by human serum.

J. McCutchan, A. Braude, S. Levine, 1976, Journal of immunology.

Evaluation of new anti-infective drugs for the treatment of syphilis. Infectious Diseases Society of America and the Food and Drug Administration.

H. Handsfield, J. McCutchan, L. Corey, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An open label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector) in HIV-1-infected subjects.

R. Haubrich, J. McCutchan, J. Merritt, 1995, Human gene therapy.

Corticosteroids as adjunctive therapy for Pneumocystis pneumonia in patients with AIDS.

P. Meier, H. Masur, J. McCutchan, 1991, The New England journal of medicine.

Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy

R. Ellis, J. McCutchan, S. Letendre, 2006, Journal of Neuroimmunology.

Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging.

D. Richman, J. Hesselink, I. Grant, 1987, Annals of internal medicine.

Human Immunodeficiency Virus-Associated Neurobehavioural Disorder

D. Richman, J. Hesselink, I. Grant, 1988, Journal of the Royal College of Physicians of London.

Unmasking of PML by HAART: Unusual clinical features and the role of IRIS

J. McCutchan, Navdeesh Sidhu, J. McCutchan, 2010, Journal of Neuroimmunology.

Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia.

I. Grant, R. Heaton, D. Clifford, 2016, Current HIV research.

Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus

D. Richman, J. McCutchan, S. Spector, 1989, Journal of Clinical Immunology.

Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization.

D. Richman, J. McCutchan, S. Spector, 1990, The Journal of infectious diseases.

Penetration and Effectiveness of Antiretroviral Therapy in the Central Nervous System

R. Ellis, J. McCutchan, S. Letendre, 2009 .

Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

F. Vaida, R. Dworkin, D. Clifford, 2010, PAIN®.

Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome

J. McCutchan, C. Wiley, Roger Behar, 1987, Neurology.

Disseminated Gonococcal Infection in Mice

J. McCutchan, R. Corbeil, J. Ito, 1979, Infection and immunity.

Plaque Assay for Measuring Serum Bactericidal Activity Against Gonococci

J. McCutchan, J. Ito, L. Corbeil, 1978, Journal of clinical microbiology.

Role of urinary solutes in natural immunity to gonorrhea

J. McCutchan, A. Braude, A. Wunderlich, 1977, Infection and immunity.

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

I. Grant, D. Clifford, R. Ellis, 2008, Archives of neurology.

Etravirine in CSF is highly protein bound.

I. Grant, D. Clifford, R. Ellis, 2013, The Journal of antimicrobial chemotherapy.

The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.

D. Richman, C. Kemper, J. McCutchan, 1995, The American journal of medicine.

The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.

D. Richman, J. McCutchan, S. Spector, 1989, The Journal of infectious diseases.

TREATMENT WITH ANTI-GRAM-NEGATIVE ANTIBODIES

J. McCutchan, E. Ziegler, 1983, The Lancet.

Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection.

C. Gallen, J. Koziol, J. McCutchan, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease.

R. Kronmal, J. Bartlett, H. Handsfield, 2000, The Journal of infectious diseases.

Disseminated Mycobacterium avium complex: correlation between blood and tissue burden.

R. Haubrich, C. Behling, D. Havlir, 1996, The Journal of infectious diseases.

Differentiation of neisseriaceae by isoenzyme electrophoresis.

J. McCutchan, A. Braude, C. Ison, 1983, The Journal of infectious diseases.

CMV-specific immune responses and HLA phenotypes of AIDS patients who develop CMV retinitis. HNRC Group. HIV Neurobehavioral Research Center.

W. Freeman, J. McCutchan, C. Wiley, 1994, Advances in neuroimmunology.

Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.

J. McCutchan, S. Letendre, E. R. Lanier, 1999, The Journal of infectious diseases.

Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus.

L. Thal, I. Grant, D. Kirson, 1993, Journal of acquired immune deficiency syndromes.

T-cell-induced expression of human immunodeficiency virus in macrophages

J. McCutchan, C. Wiley, J. Nelson, 1990, Journal of virology.

Population Pharmacokinetics of Abacavir in Plasma and Cerebrospinal Fluid

R. Ellis, J. McCutchan, S. Letendre, 2005, Antimicrobial Agents and Chemotherapy.

HAEMOPHILUS PARAINFLUENZAE INFECTIVE ENDOCARDITIS

E. J. Young, J. McCutchan, D. Gilbert, 1977, Medicine.

Cluster Analysis of the Klein Sexual Orientation Grid in Clinical and Nonclinical Samples: When Bisexuality Is Not Bisexuality

I. Grant, J. McCutchan, F. Klein, 2014, Journal of bisexuality.

Evaluation of new anti-infective drugs for the treatment of uncomplicated gonorrhea in adults and adolescents. Infectious Diseases Society of America and the Food and Drug Administration.

H. Handsfield, J. McCutchan, L. Corey, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum.

J. McCutchan, E. Ziegler, A. Braude, 1975, Transactions of the Association of American Physicians.

PREVENTING DEATH FROM SHOCK BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID

W. Knaus, R. Freeman, J. McCutchan, 1985, The Lancet.

TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SHOCK WITH HUMAN ANTISERUM TO A MUTANT ESCHERICHIA COLI

J. McCutchan, J. Fierer, J. Sadoff, 1983 .

Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.

J. McCutchan, E. Ziegler, A. Braude, 1977, Journal of Infectious Diseases.

Deficiency of erythrocyte C3b receptor (CR1) in AIDS and AIDS-related syndromes

R. Schreiber, J. McCutchan, I. Gigli, 1986, Bioscience reports.

HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter

David J. Miller, Michael J. Taylor, Greg G. Brown, 2014, Journal of NeuroVirology.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

Michael J. Taylor, A. Gamst, C. Fennema-Notestine, 2010, Neurology.

Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS.

J. McCutchan, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.

D Johnson, R. Haubrich, G. Beall, 1999, AIDS.

Treatment of Toxoplasmic Encephalitis in Patients with AIDS

N Clumeck, J. McCutchan, B. Luft, 1992, Annals of Internal Medicine.

Review of medical microbiology

J. McCutchan, A. Braude, 1983 .

Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS.

D. Richman, J. McCutchan, S. Bozzette, 1991, Annals of internal medicine.

Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.

D. Richman, J. McCutchan, S. Bozzette, 1989, Annals of internal medicine.

Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.

R. Haubrich, J. McCutchan, S. Bozzette, 2008, Medical mycology.

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

J. McCutchan, S. Bozzette, D. Forthal, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group.

R. Haubrich, J. McCutchan, S. Bozzette, 1994, The Journal of infectious diseases.

Marked elevation of the serum ferritin is highly specific for disseminated histoplasmosis in AIDS.

J. McCutchan, D. Stites, M. Shuman, 1995, AIDS.

Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis.

J. McCutchan, D. Stites, M. Shuman, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cryptosporidiosis of the stomach and small intestine in patients with AIDS.

A. Megibow, J. McCutchan, A. Clemett, 1984, AJR. American journal of roentgenology.

Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.

J. McCutchan, B. Parker, E. Muchmore, 1991, The American journal of medicine.

Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.

K. Sepkowitz, C. Kemper, D. Havlir, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir

I. Grant, D. Clifford, R. Ellis, 2012, Journal of acquired immune deficiency syndromes.

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome.

W. Freeman, I. Abramson, J. McCutchan, 1990, Ophthalmology.

Cytomegalovirus infections of the nervous system in patients with AIDS.

J. McCutchan, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group.

W. Freeman, J. McCutchan, C. Wiley, 1995, The Journal of clinical investigation.

Identification of Cryptosporidium in patients with the acquired immunodeficiency syndrome.

J. McCutchan, M. Heinzman, McCutchan Ja, 1983, The New England journal of medicine.

Evaluation of new anti-infective drugs for the treatment of genital infections due to herpes simplex virus. Infectious Diseases Society of America and the Food and Drug Administration.

H. Handsfield, J. McCutchan, L. Corey, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection.

M. Cronin, J. McCutchan, W. Wachsman, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects

I. Grant, R. Heaton, D. Clifford, 2019, AIDS.

Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.

I. Grant, C. Spina, J. McCutchan, 1996, The Journal of clinical investigation.

Neurologic complications of HIV disease and their treatment.

B. Ances, R. Ellis, J. McCutchan, 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Evaluation of new anti-infective drugs for the treatment of sexually transmitted chlamydial infections and related clinical syndromes. Infectious Diseases Society of America and the Food and Drug Administration.

H. Handsfield, J. McCutchan, L. Corey, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

J. McCutchan, M. Kilpatrick, W. O. Harrison, 1979, The New England journal of medicine.

A Randomized Controlled Trial of Therapeutic Drug Monitoring in Treatment-Naive and -Experienced HIV-1-Infected Patients

R. Haubrich, C. Kemper, J. McCutchan, 2007, Journal of acquired immune deficiency syndromes.

Use of and Adherence to Antiretroviral Therapy Is Associated With Decreased Sexual Risk Behavior in HIV Clinic Patients

C. Kemper, J. McCutchan, R. Bolan, 2005, Journal of acquired immune deficiency syndromes.

Rhabdomyolysis and Staphylococcus aureus septicemia in a man with the acquired immunodeficiency syndrome.

K. Benirschke, J. McCutchan, A. W. Wu, 1990, The Western journal of medicine.

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV.

R. Haubrich, I. Grant, D. Clifford, 2011, The Journal of antimicrobial chemotherapy.

The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk

I. Grant, R. Ellis, J. McCutchan, 2014, Psychiatry Research.

Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy

D. Richman, I. Grant, H. Günthard, 2005, Journal of Virology.

A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus.

D. Richman, J. McCutchan, S. Spector, 1993, The Journal of infectious diseases.

PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID

J. McCutchan, R. Chioléro, M. Klauber, 1985, The Lancet.

Immunization against nosocomial infection.

J. McCutchan, E. Ziegler, A. Braude, 1981, The American journal of medicine.

Successful treatment of human gram-negative bacteremia with antiserum against endotoxin core.

J. McCutchan, E. Ziegler, A. Braude, 1981, Transactions of the Association of American Physicians.

Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin.

J. McCutchan, E. Ziegler, A. Braude, 1979, European journal of cancer.

Treatment of gram-negative bacteremia with antiserum to core glycolipid II. A controlled trial of antiserum in patients with bacteremia.

J. McCutchan, E. Ziegler, A. Braude, 1979, European Journal of Cancer.

Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia.

J. McCutchan, E. Ziegler, J. Wolf, 1983, Schweizerische medizinische Wochenschrift. Supplementum.

Role of blocking antibody in disseminated gonococcal infection.

D. Katzenstein, J. McCutchan, A. Braude, 1978, Journal of immunology.

A factor analysis of the Klein sexual orientation Grid in two disparate samples

I. Grant, J. McCutchan, R. Pillard, 1993, Archives of sexual behavior.

Patterns of Selective Neuronal Damage in Methamphetamine-User AIDS Patients

E. Masliah, I. Grant, R. Ellis, 2003, Journal of acquired immune deficiency syndromes.

Lifetime suicidal ideation and attempt are common among HIV+ individuals.

F. Vaida, I. Grant, R. Heaton, 2012, Journal of affective disorders.

White matter damage, neuroinflammation, and neuronal integrity in HAND

C. Fennema-Notestine, I. Grant, R. Heaton, 2018, Journal of NeuroVirology.

Treatment of acute toxoplasmosis with intravenous clindamycin

J. McCutchan, B. Luft, P. Morlat, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group.

I. Grant, J. McCutchan, M. Wallace, 1993, The Journal of infectious diseases.

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neurocognitive Impact of Substance Use in HIV Infection

I. Grant, R. Heaton, D. Clifford, 2011, Journal of acquired immune deficiency syndromes.

Genetic attributes of cerebrospinal fluid-derived HIV-1 env.

D. Richman, I. Grant, H. Günthard, 2006, Brain : a journal of neurology.

Detecting human immunodeficiency virus RNA in peripheral blood mononuclear cells by nucleic acid hybridization.

D. Richman, J. McCutchan, S. Spector, 1987, The Journal of infectious diseases.

A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy.

R. Haubrich, G. Beall, C. Kemper, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Immunodeficiency Virus Replication in AIDS Patients with Mycobacterium avium Complex Bacteremia: A Case Control Study

R. Haubrich, D. Richman, D. Havlir, 1998 .

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

Anthony Gamst, Justin C McArthur, Ian Abramson, 2014, Neurology.

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

T. Jernigan, E. Masliah, I. Grant, 2002, AIDS.

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat

D. Richman, R. Heaton, D. Clifford, 2012, Journal of NeuroVirology.

Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment

I. Grant, T. Wolfson, J. McCutchan, 2001, Sexually transmitted infections.

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Sergei L. Kosakovsky Pond, D. Richman, I. Grant, 2012, Virology.

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

I. Grant, R. Heaton, R. Ellis, 1997, Annals of neurology.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

Susan Morgello, David Clifford, Florin Vaida, 2011, AIDS.

Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion.

I. Grant, R. Heaton, R. Ellis, 2003, Archives of neurology.

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

I. Grant, R. Heaton, R. Ellis, 2002, Archives of neurology.

Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.

S. Frost, R. Ellis, J. McCutchan, 2003, The Journal of infectious diseases.

Characterizing HIV Medication Adherence for Virologic Success Among Individuals Living With HIV/AIDS: Experience With the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Cohort

E. Spitznagel, D. Clifford, J. McCutchan, 2014, Journal of HIV/AIDS & social services.

Identification of psychobiological stressors among HIV-positive women. HIV Neurobehavioral Research Center (HNRC) Group.

T. Patterson, I. Grant, J. McCutchan, 1993, Women & health.

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

Michael J. Taylor, R. Heaton, R. Ellis, 2007, AIDS.

The Correlation between Plasma Concentrations of Protease Inhibitors, Medication Adherence and Virological Outcome in HIV-Infected Patients

R. Haubrich, G. Beall, C. Kemper, 2004, Antiviral therapy.

The Relationship Between Neuropsychological Functioning and Coping Activity Among HIV-Positive Men

T. Patterson, I. Grant, R. Heaton, 1997, AIDS and Behavior.

The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection.

I. Abramson, J. McCutchan, S. Spector, 1991, The Journal of infectious diseases.

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l

J. McCutchan, D. Finkelstein, J. Currier, 2001, AIDS.

Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection

D. Richman, J. McCutchan, S. Spector, 1987, Journal of clinical microbiology.

Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV

R. Heaton, D. Clifford, R. Ellis, 2022, Journal of acquired immune deficiency syndromes.

Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.

Jessica L. Montoya, D. Jeste, R. Heaton, 2019, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Effects of recalled childhood gender nonconformity on adult genitoerotic role and AIDS exposure

I. Grant, J. McCutchan, J. Weinrich, 1992, Archives of sexual behavior.

HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging.

Richard B Buxton, Florin Vaida, F. Vaida, 2010, The Journal of infectious diseases.

Endoscopic diagnosis and management of hepatobiliary tuberculosis.

T. Savides, J. McCutchan, E. Bearer, 1996, The American journal of gastroenterology.

Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.

N. Roberts, J. McCutchan, M. McElrath, 2003, The Journal of infectious diseases.

Fatigue, sleep disturbance, disability, and indices of progression of HIV infection.

D. Kripke, J. McCutchan, J. Gillin, 1992, The American journal of psychiatry.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States

I. Grant, R. Heaton, D. Clifford, 2017, Journal of the International Neuropsychological Society.

Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years

R. Heaton, D. Clifford, R. Ellis, 2022, Brain, behavior, & immunity - health.

Genome‐wide association study of HIV‐associated neurocognitive disorder (HAND): A CHARTER group study

Zhongming Zhao, N. Schork, P. Jia, 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era

W. Freeman, I. Grant, R. Heaton, 2004, Ocular immunology and inflammation.

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

A. Gamst, I. Grant, R. Ellis, 2000, Neurology.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

F. Vaida, C. Fennema-Notestine, R. Heaton, 2017, The Journal of infectious diseases.

Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis

R. Heaton, J. McCutchan, D. Franklin, 2019, Journal of acquired immune deficiency syndromes.

Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-Associated Neurocognitive Disorders in the CHARTER Cohort

I. Grant, R. Heaton, D. Clifford, 2013, Journal of acquired immune deficiency syndromes.

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

I. Grant, B. Ances, R. Heaton, 2012, Neurology.

Contents of the American Journal of Psychiatry

P. Schnurr, L. Felch, J. Rosenbaum, 1992, Psychological Medicine.

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Suzanne A. Moseley, F. Vaida, I. Grant, 2011, The Journal of neuropsychiatry and clinical neurosciences.

Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV

R. Heaton, D. Clifford, R. Ellis, 2020, Brain, behavior, & immunity - health.

Improved tuberculosis smear detection in resource-limited settings: Combined bleach concentration and LED fluorescence microscopy.

J. McCutchan, E. Lemma, S. Reed, 2011, International health.

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.

I. Grant, D. Clifford, R. Ellis, 2013, The Journal of antimicrobial chemotherapy.

Paresthesia Predicts Increased Risk of Distal Neuropathic Pain in Older People with HIV-Associated Sensory Polyneuropathy.

A. Simmons, F. Vaida, I. Grant, 2021, Pain medicine.

Epidemiology of venereal urethritis: comparison of gonorrhea and nongonococcal urethritis.

J. McCutchan, J A McCutchan, 1984, Reviews of infectious diseases.

Survey of cases of gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae in the United Kingdom.

J. McCutchan, M. Adler, 1985, Genitourinary medicine.

Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission.

J. McCutchan, M. Adler, J. Berrie, 1982, British medical journal.

Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners

R. Haubrich, J. McCutchan, Sonia Jain, 2019, PloS one.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

F. Vaida, I. Grant, D. Clifford, 2019, The lancet. HIV.

Neurocognitive impairment in HIV-infected individuals with previous syphilis

I. Grant, R. Heaton, D. Clifford, 2013, International journal of STD & AIDS.

Relationship of psychosocial factors to HIV disease progression

Shirley J. Semple, Thomas L. Patterson, William S. Shaw, 1996, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

Prevalence and Risk Factors for Human Immunodeficiency Virus (HIV) and Syphilis Infections Among Military Personnel in Sierra Leone.

J. McCutchan, Sonia Jain, R. Shaffer, 2017, Current HIV research.

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER

I. Grant, D. Clifford, M. Ritchie, 2012, Journal of NeuroVirology.

Do Patients With HIV-Associated Minor Cognitive/Motor Disorder Exhibit a “Subcortical” Memory Profile? Evidence Using the California Verbal Learning Test

Michael J. Taylor, D. Delis, D. Salmon, 1995 .

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

I. Grant, R. Ellis, J. McCutchan, 2011, Journal of NeuroVirology.

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

I. Grant, R. Heaton, R. Ellis, 2004, Annals of neurology.

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.

R. Haubrich, F. Vaida, R. Heaton, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon

R. Heaton, R. Ellis, J. McCutchan, 2010, BMC neurology.

The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis

R. Haubrich, D. Richman, C. Kemper, 2002, AIDS.

Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors

R. Haubrich, D. Richman, C. Kemper, 2001, AIDS.

Validity of the Quality of Well-Being Scale for Persons With Human Immunodeficiency Virus Infection

R M Kaplan, I Grant, J H Atkinson, 1995, Psychosomatic medicine.

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients

E. Masliah, I. Grant, R. Ellis, 2011, Journal of NeuroVirology.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

F. Vaida, C. Fennema-Notestine, A. Gamst, 2013, Journal of NeuroVirology.

The Role of Cohort Studies in Drug Development: Clinical Evidence of Antiviral Activity of Serotonin Reuptake Inhibitors and HMG-CoA Reductase Inhibitors in the Central Nervous System

I. Grant, R. Heaton, D. Clifford, 2007, Journal of Neuroimmune Pharmacology.

Evaluation of new anti-infective drugs for the treatment of chancroid. Infectious Diseases Society of America and the Food and Drug Administration.

H. Handsfield, J. McCutchan, L. Corey, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates

Jessica L. Montoya, D. Jeste, I. Grant, 2019, Journal of the International Neuropsychological Society.

Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study.

R. Heaton, D. Clifford, R. Ellis, 2022, Brain : a journal of neurology.

Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment.

J. McCutchan, A. Mindel, M. Adler, 1983, British medical journal.

Depressive Symptoms Among HIV Positive Men: Life Stress, Coping, and Social Support1

T. Patterson, I. Grant, J. McCutchan, 1993 .

Acquired Immunodeficiency Syndrome: Mangnetic Resonance Patterns of Brain Involvement With Pathologic Correlation

D. Richman, J. Hesselink, R. Teschke, 1988 .

Relationships Among Neurocognitive Status, Medication Adherence Measured by Pharmacy Refill Records, and Virologic Suppression in HIV-Infected Persons

I. Grant, J. McCutchan, J. Atkinson, 2013, Journal of acquired immune deficiency syndromes.

Anemia and Erythrocyte Indices Are Associated With Neurocognitive Performance Across Multiple Ability Domains in Adults With HIV

R. Heaton, R. Ellis, J. McCutchan, 2022, Journal of acquired immune deficiency syndromes.

Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex.

I Grant, J H Atkinson, A. Wu, 1990, Journal of acquired immune deficiency syndromes.

Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances

Jessica L. Montoya, D. Jeste, R. Ellis, 2020, Journal of NeuroVirology.

Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy

B. Ances, R. Ellis, J. McCutchan, 2011, AIDS.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

I. Grant, R. Heaton, J. Connor, 2018, Molecular Neurobiology.

Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation

I. Grant, R. Heaton, D. Clifford, 2015, Journal of acquired immune deficiency syndromes.

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease

I. Grant, R. Heaton, R. Ellis, 2005, AIDS.

The relationship between loneliness, interpersonal competence, and immunologic status in hiv-infected men

P. G. Roth, Shirley J. Semple, Thomas L. Patterson, 1994 .

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy.

I. Grant, R. Ellis, J. McCutchan, 2001, AIDS.

Magnetic Resonance Imaging Morphometric Analysis of Cerebral Volume Loss in Human Immunodeficiency Virus Infection

Terry L. Jernigan, T. Jernigan, J. Hesselink, 1993 .

Knowledge, Attitudes, and Practice Regarding Research Ethics Committees Among Health Care Faculty at Two Public Universities in Jordan

J. McCutchan, N. Ayoub, A. Qandil, 2019, Journal of empirical research on human research ethics : JERHRE.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

I. Grant, D. Murdock, R. Heaton, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group.

I Grant, J H Atkinson, J R Hesselink, 1993, Archives of neurology.

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy

I. Grant, D. Clifford, R. Ellis, 2008, Annals of neurology.

Role of metabolic syndrome components in HIV-associated sensory neuropathy

F. Vaida, I. Grant, B. Ances, 2009, AIDS (London).

Psychiatric Context of Acute/Early HIV Infection. The NIMH Multisite Acute HIV Infection Study: IV

Wayne T. Steward, I. Grant, R. Remien, 2009, AIDS and Behavior.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

F. Vaida, C. Fennema-Notestine, A. Gamst, 2013, Journal of NeuroVirology.

Neuroleptic Treatment of HIV-Associated Psychosis

D. Jeste, I. Grant, J. McCutchan, 1994, Neuropsychopharmacology.

Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection.

A. Wu, H. Rubin, I. Grant, 1993, Journal of acquired immune deficiency syndromes.

Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV

I. Grant, R. Heaton, D. Clifford, 2012, AIDS and Behavior.

Prevalence and risk factors for HIV CSF Viral Escape: Results from the CHARTER and HNRP cohorts

I. Grant, R. Heaton, D. Clifford, 2012 .

Brief Report: Body Mass Index and Cognitive Function Among HIV-1–Infected Individuals in China, India, and Nigeria

W. Blattner, L. Magder, I. Grant, 2019, Journal of acquired immune deficiency syndromes.

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

Michael J. Taylor, Gregory G. Brown, T. Patterson, 2005, Journal of NeuroVirology.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Zhongming Zhao, P. Jia, I. Grant, 2016, The Journal of infectious diseases.

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

C. Fennema-Notestine, T. Jernigan, I. Grant, 2014, Journal of NeuroVirology.

Therapeutic Amprenavir Concentrations in Cerebrospinal Fluid

I. Grant, D. Clifford, R. Ellis, 2012, Antimicrobial Agents and Chemotherapy.

Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

W. Blattner, I. Grant, R. Ellis, 2012, Journal of NeuroVirology.

Stress and Depressive Symptoms Prospectively Predict Immune Change among HIV-Seropositive Men.

T. Patterson, I. Grant, J. McCutchan, 1995, Psychiatry.

Neuropsychological impairment in human immunodeficiency virus‐infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center.

I Grant, J H Atkinson, H P Godfrey, 1994, Psychosomatic medicine.

Cerebrospinal Fluid β Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1

J. McCutchan, S. Letendre, E. R. Lanier, 1999 .

HIV-1 neurocognitive disorders and chemokine receptors.

I. Grant, R. Heaton, R. Ellis, 1997, AIDS (London).

Role of metabolic syndrome components in human immunodeficiency virus-associated stroke

F. Vaida, I. Grant, B. Ances, 2009, Journal of NeuroVirology.

Sex-specific associations between plasma interleukin-6 and depression in persons with and without HIV

Kalen J. Petersen, R. Ellis, J. McCutchan, 2023, Brain, behavior, & immunity - health.

Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort.

D. Richman, J. Hesselink, I. Grant, 1992, The Journal of Neuropsychiatry and Clinical Neurosciences.

Cerebrospinal Fluid b Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1

J. McCutchan, S. Letendre, E. R. Lanier, 1999 .

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining “symptomatic” versus “asymptomatic” HAND

F. Vaida, C. Fennema-Notestine, I. Grant, 2016, Journal of NeuroVirology.

A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575

R. Haubrich, D. Richman, C. Kemper, 2005, AIDS.

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat

D. Richman, I. Grant, R. Heaton, 2012, Journal of NeuroVirology.

Meeting Practical Challenges of a Trial Involving a Multitude of Treatment Regimens: An Example of a Multi-Center Randomized Controlled Clinical Trial in NeuroAIDS

R. Haubrich, R. Heaton, R. Ellis, 2007, Journal of Neuroimmune Pharmacology.

Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals.

J. McCutchan, P. Nara, C. Kang, 1994, AIDS research and human retroviruses.

Indinavir Population Pharmacokinetics in Plasma and Cerebrospinal Fluid

J. McCutchan, S. Letendre, E. Capparelli, 2000, Antimicrobial Agents and Chemotherapy.

White matter damage, neuroinflammation, and neuronal integrity in HAND

C. Fennema-Notestine, I. Grant, R. Heaton, 2018, Journal of NeuroVirology.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals

F. Vaida, C. Fennema-Notestine, B. Ances, 2016, Journal of Neurovirology.

The influence of HIV-related support groups on survival in women who lived with HIV. A pilot study.

T. Patterson, I. Grant, J. McCutchan, 2000, Psychosomatics.

Antiserum treatment of gram-negative bacteremia.

J. McCutchan, E. Ziegler, A. Braude, 1978, Schweizerische medizinische Wochenschrift.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

I. Grant, R. Heaton, D. Clifford, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir

I. Grant, D. Clifford, R. Ellis, 2012, Journal of acquired immune deficiency syndromes.

Reply to Haddow et al.

F. Vaida, C. Fennema-Notestine, A. Gamst, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Michael J. Taylor, C. Fennema-Notestine, T. Jernigan, 2010, Journal of NeuroVirology.

Clinical factors related to brain structure in HIV: the CHARTER study

Michael J. Taylor, C. Fennema-Notestine, T. Jernigan, 2011, Journal of NeuroVirology.

HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon

R. Heaton, R. Ellis, J. McCutchan, 2010, BMC neurology.

Better Biomarkers Are Needed to Improve the Management of the Neurologic Complications of HIV Infection

R. Ellis, J. McCutchan, S. Letendre, 2008 .

Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis

J. McCutchan, C. Achim, C. Wiley, 1992, AIDS.

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.

R. Haubrich, F. Vaida, J. McCutchan, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

I. Grant, R. Ellis, J. McCutchan, 2011, Journal of NeuroVirology.

Etravirine in CSF is highly protein bound.

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2013, The Journal of antimicrobial chemotherapy.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates

Jessica L. Montoya, D. Jeste, I. Grant, 2019, Journal of the International Neuropsychological Society.